gepirone Tablets, extended release (ER) 18.2 mg, 36.3 mg, 54.4 mg, 72.6 mg

Established in 2009, this manufacturer specializes in active pharmaceutical ingredients (APIs) and finished formulations, including tablets, capsules, and liquid orals. As a CTD dossier owner and manufacturer, it holds GMP certifications from international regulatory authorities, including the U.S. FDA and EU GMP, ensuring compliance with stringent quality standards. The manufacturer operates state-of-the-art production facilities in Vadodara and Vapi, India, adhering to rigorous GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed across various regions, including Europe, East Asia, South America, and the Middle East. With a strong focus on research and development, the manufacturer is committed to delivering high-quality pharmaceutical solutions to meet global healthcare needs.